The challenges in predicting ECMO survival, and a path forward.

Marco Huesch, Christopher Brehm

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Extracorporeal membrane oxygenation (ECMO) support is a life-saving but complex technique for patients suffering from severe cardiac and/or pulmonary dysfunction. Increasingly greater utilization in the last 15 years means that a suite of mortality risk analytics is both feasible for researchers and required by clinicians, patients, administrators and insurers. We argue that to date, research into such risk analytics has been insufficient and does not adequately reflect the various indications and configurations of ECLS. We propose a path to address these challenges and ensure that clinicians and researchers obtain robust, specific, risk analytics.This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Original languageEnglish (US)
JournalASAIO Journal
DOIs
StateAccepted/In press - Mar 22 2017

Fingerprint

Extracorporeal Membrane Oxygenation
Oxygenation
Membranes
Survival
Research Personnel
Insurance Carriers
Licensure
Administrative Personnel
Derivatives
Lung
Mortality
Research

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Biomedical Engineering

Cite this

@article{43e992b87c69431abe4ad38ab53017e4,
title = "The challenges in predicting ECMO survival, and a path forward.",
abstract = "Extracorporeal membrane oxygenation (ECMO) support is a life-saving but complex technique for patients suffering from severe cardiac and/or pulmonary dysfunction. Increasingly greater utilization in the last 15 years means that a suite of mortality risk analytics is both feasible for researchers and required by clinicians, patients, administrators and insurers. We argue that to date, research into such risk analytics has been insufficient and does not adequately reflect the various indications and configurations of ECLS. We propose a path to address these challenges and ensure that clinicians and researchers obtain robust, specific, risk analytics.This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.",
author = "Marco Huesch and Christopher Brehm",
year = "2017",
month = "3",
day = "22",
doi = "10.1097/MAT.0000000000000572",
language = "English (US)",
journal = "ASAIO Journal",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",

}

The challenges in predicting ECMO survival, and a path forward. / Huesch, Marco; Brehm, Christopher.

In: ASAIO Journal, 22.03.2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The challenges in predicting ECMO survival, and a path forward.

AU - Huesch, Marco

AU - Brehm, Christopher

PY - 2017/3/22

Y1 - 2017/3/22

N2 - Extracorporeal membrane oxygenation (ECMO) support is a life-saving but complex technique for patients suffering from severe cardiac and/or pulmonary dysfunction. Increasingly greater utilization in the last 15 years means that a suite of mortality risk analytics is both feasible for researchers and required by clinicians, patients, administrators and insurers. We argue that to date, research into such risk analytics has been insufficient and does not adequately reflect the various indications and configurations of ECLS. We propose a path to address these challenges and ensure that clinicians and researchers obtain robust, specific, risk analytics.This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

AB - Extracorporeal membrane oxygenation (ECMO) support is a life-saving but complex technique for patients suffering from severe cardiac and/or pulmonary dysfunction. Increasingly greater utilization in the last 15 years means that a suite of mortality risk analytics is both feasible for researchers and required by clinicians, patients, administrators and insurers. We argue that to date, research into such risk analytics has been insufficient and does not adequately reflect the various indications and configurations of ECLS. We propose a path to address these challenges and ensure that clinicians and researchers obtain robust, specific, risk analytics.This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

UR - http://www.scopus.com/inward/record.url?scp=85016082565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016082565&partnerID=8YFLogxK

U2 - 10.1097/MAT.0000000000000572

DO - 10.1097/MAT.0000000000000572

M3 - Article

C2 - 28338480

AN - SCOPUS:85016082565

JO - ASAIO Journal

JF - ASAIO Journal

SN - 1058-2916

ER -